Abstract
Fresh frozen plasma (FFP) is widely used in liver diseases to rectify coagulation derangements. In this study we have analysed the pattern of FFP usage in liver diseases and its effect on International normalized ratio (INR). A retrospective study of liver disease patients who received FFP transfusions from January 2016 to June 2016 was done. FFP used for liver transplant surgeries and plasma exchange procedures were excluded from the study. A total of 1935 units of FFP were transfused to 576 patients. We found a high linear correlation between pre transfusion INR and change in INR per unit of FFP. Patients receiving 6 units or more FFP have shown significant INR improvement. Improvement was more in acute liver failure and acute on chronic liver failure cases compared to chronic liver disease. FFP is not effective in correcting mild to moderate coagulation defects in liver diseases. Large volumes are required to cause significant INR improvement. Considering the risks associated with FFP transfusion, decision of transfusion should be carefully weighed. Future prospective randomized control trails are required for understanding the risk benefit ratio better and formulating plasma transfusion guidelines in liver diseases.
References
Stanworth SJ (2007) The evidence based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. In: Hematology. American Society of Hematology Educational Program, pp 179–186
Abdel-Wahab Omar I, Healy Brian, Dzik Walter H (2006) Effect of FFP transfusion on PT and bleeding in patients with mild coagulation abnormalities. Transfusion 46(8):1279–1285
Youssef WI, Salazar F, Dasarathy S, Beddow T, Mullen KD (2003) Role of FFP infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol 98(6):1391–1394
Stanworth SJ, Brunskill SJ, Hyde CJ, Murphy MF, McClelland DB (2004) Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 126(1):139–152
Lisman T, Caldwell SH, Burroughs et al (2010) Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 53:362–371
Holland LL, Brooke JP (2006) Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 126(1):133–139
Caldwell SH (2014) Management of coagulopathy in liver disease. Gastroenterol Hepatol 10(5):330–332
American Association of Blood banks (2002) Technical manual, 14th edn. AABB, Bethesda, pp 461–465
Wong MP, Droubatchevskaia N, Chipperfield KM, Wadsworth LD, Ferguson DJ (2007) Guidelines for frozen plasma transfusion. BCMJ 49(6):311–319
Hshieh TT, Kaung A, Hussain S, Curry MP, Sundaram V (2015) The international normalized ratio does not reflect bleeding risk in esophageal variceal hemorrhage. Saudi J Gastroenterol 21:254–258
Pandit TN, Sarode R (2012) Blood component support in acquired coagulopathic conditions: Is there a method to the madness? Am J Hematol 87:S56–S62
Shinagare SA, Angarkar NN, Desai SR, Naniwadekar MR (2010) An audit of fresh frozen plasma usage and effect of fresh frozen plasma on the pre-transfusion international normalized ratio. Asian J Transfus Sci 4:128–132
Amarapurkar PD, Amarapurkar DN (2011) Management of coagulopathy in patients with decompensated liver cirrhosis. Int J Hepatol 2011:695470
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Baruah, S., Bajpai, M. Effect of FFP Transfusion on International Normalized Ratio in Liver Disease Patients. Indian J Hematol Blood Transfus 34, 719–722 (2018). https://doi.org/10.1007/s12288-018-0934-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-018-0934-0